Redox modulation of adipocyte differentiation: Hypothesis of "redox Chain" and novel insights into intervention of adipogenesis and obesity

Free Radical Biology and Medicine

Volumn 89, Issue , 2015, Pages 99-125

  Wang, Xin ^a   Hai, Chunxu ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adipocyte differentiation; Antioxidant; Epigenetic modulation; Obesity; Post translational modification; Redox; ROS; Transcription factor

Indexed keywords

ANTIOXIDANT; CATALASE; CYTOCHROME P450; GLUCOCORTICOID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; HEME OXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; ISOBUTYLMETHYLXANTHINE; LIPOXYGENASE; METALLOTHIONEIN; NADPH QUINONE OXIDOREDUCTASE 1; NATURAL PRODUCT; NITRIC OXIDE SYNTHASE; PEROXIREDOXIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROSTAGLANDIN SYNTHASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELENOPROTEIN; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; ENDOPLASMIC RETICULUM; EPIGENETICS; EXPERIMENTAL MODEL; HUMAN; IN VITRO STUDY; MITOCHONDRION; MULTIPOTENT STEM CELL; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PROCESSING; REVIEW; ANIMAL; CYTOLOGY;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; HUMANS; OBESITY; OXIDATION-REDUCTION;

EID: 84942432196     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.07.012     Document Type: Review

References (450)

1. Y.H. Tseng, A.M. Cypess, and C.R. Kahn Cellular bioenergetics as a target for obesity therapy Nat. Rev. Drug Discov. 9 2010 465 482
2. C.L. Ogden, M.D. Carroll, B.K. Kit, and K.M. Flegal Prevalence of obesity in the Unites States, 2009-2010 NCHS Data Brief 82 2012 1 8
3. P.G. Kopelman Obesity as a medical problem Nature 404 2000 635 643
4. D.W. Haslam, and W.P. James Obesity Lancet 366 2005 1197 1209
5. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, and D.M. Nathan Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N. Engl. J. Med. 346 2002 393 403
6. D.H. Ryan, and G.A. Bray Pharmacologic treatment options for obesity: what is old is new again Curr. Hypertens. Rep. 15 2013 182 189
7. P. Behary, J. Cegla, T.M. Tan, and S.R. Bloom Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones Postgrad. Med. 127 2015 494 502
8. S. O'Rahilly Human genetics illuminates the paths to metabolic disease Nature 462 2009 307 314
9. M.L. Isidro, and F. Cordido Drug treatment of obesity: established and emerging therapies Mini. Rev. Med. Chem 9 2009 664 673
10. S.M. Grundy Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy Nat. Rev. Drug Discov. 5 2006 295 309
11. A.J. Whittle, M. Lopez, and A. Vidal-Puig Using brown adipose tissue to treat obesity - the central issue Trends Mol. Med. 17 2011 405 411
12. S. Di Caro, G.G. Hamad, M.H. Fernstrom, P.R. Schauer, and G. Bonanomi Medical strategies for weight loss in the overweight and obese patient Minerva Gastroenterol. Dietol. 52 2006 415 430
13. G.A. Bray, and L.A. Tartaglia Medicinal strategies in the treatment of obesity Nature 404 2000 672 677
14. P.E. Scherer Adipose tissue: from lipid storage compartment to endocrine organ Diabetes 55 2006 1537 1545
15. U.B. Pajvani, M.E. Trujillo, T.P. Combs, P. Iyengar, L. Jelicks, K.A. Roth, R.N. Kitsis, and P.E. Scherer Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy Nat. Med 11 2005 797 803
16. H. Yki-Jarvinen Fat in the liver and insulin resistance Ann. Med. 37 2005 347 356
17. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat. Rev. Immunol. 11 2011 85 97
18. S. Galic, J.S. Oakhill, and G.R. Steinberg Adipose tissue as an endocrine organ Mol. Cell Endocrinol. 316 2010 129 139
19. R.E. Gimeno, and L.D. Klaman Adipose tissue as an active endocrine organ: recent advances Curr. Opin. Pharmacol. 5 2005 122 128
20. A.H. Berg, and P.E. Scherer Adipose tissue, inflammation, and cardiovascular disease Circ Res 96 2005 939 949
21. P. Trayhurn, and I.S. Wood Adipokines: inflammation and the pleiotropic role of white adipose tissue Br. J. Nutr. 92 2004 347 355
22. G. Li, W. Yao, and H. Jiang Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue J. Nutr. 144 2014 1887 1895
23. L. Casteilla, V. Planat-Benard, P. Laharrague, and B. Cousin Adipose-derived stromal cells: their identity and uses in clinical trials, an update World J. Stem Cells 3 2011 25 33
24. S.P. Poulos, M.V. Dodson, and G.J. Hausman Cell line models for differentiation: preadipocytes and adipocytes Exp. Biol. Med. (Maywood) 235 2010 1185 1193
25. G. Lin, M. Garcia, H. Ning, L. Banie, Y.L. Guo, T.F. Lue, and C.S. Lin Defining stem and progenitor cells within adipose tissue Stem Cells Dev. 17 2008 1053 1063
26. M.E. Morris, J.E. Beare, R.M. Reed, J.R. Dale, A.J. LeBlanc, C.L. Kaufman, H. Zheng, C.K. Ng, S.K. Williams, and J.B. Hoying Systemically delivered adipose stromal vascular fraction cells disseminate to peripheral artery walls and reduce vasomotor tone through a CD11b+ cell-dependent mechanism Stem Cells Transl. Med 4 2015 369 380
27. G. Garruti, and D. Ricquier Analysis of uncoupling protein and its mRNA in adipose tissue deposits of adult humans Int. J. Obes. Relat. Metab. Disord 16 1992 383 390
28. J.B. Hansen, and K. Kristiansen Regulatory circuits controlling white versus brown adipocyte differentiation Biochem. J. 398 2006 153 168
29. P. Bjorntorp, and L. Sjöström Number and size of adipose tissue fat cells in relation to metabolism in human obesity Metabolism 20 1971 703 713
30. B.M. Spiegelman, and J.S. Flier Adipogenesis and obesity: rounding out the big picture Cell 87 1996 377 389
31. M. Krotkiewski, L. Sjostrom, P. Bjorntorp, G. Carlgren, G. Garellick, and U. Smith Adipose tissue cellularity in relation to prognosis for weight reduction Int. J. Obes. 1 1977 395 416
32. J.P. Bastard, M. Maachi, J.T. Van Nhieu, C. Jardel, E. Bruckert, A. Grimaldi, J.J. Robert, J. Capeau, and B. Hainque Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro J. Clin. Endocrinol. Metab. 87 2002 2084 2089
33. P. Björntorp, C. Bengtsson, G. Blohmé, A. Jonsson, L. Sjöström, E. Tibblin, G. Tibblin, and L. Wilhelmsen Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women Metabolism 20 1971 927 935
34. T. Skurk, C. Alberti-Huber, C. Herder, and H. Hauner Relationship between adipocyte size and adipokine expression and secretion J. Clin. Endocrinol. Metab. 92 2007 1023 1033
35. J. O'Connell, L. Lynch, T.J. Cawood, A. Kwasnik, N. Nolan, J. Geoghegan, A. McCormick, C. O'Farrelly, and D. O'Shea The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity PLos One 5 2010 e9997
36. J. Koska, N. Stefan, S. Dubois, C. Trinidad, R.V. Considine, T. Funahashi, J.C. Bunt, E. Ravussin, and P.A. Permana mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action Int. J. Obes. (Lond.) 33 2009 842 850
37. C. Maffeis, D. Silvagni, R. Bonadonna, A. Grezzani, C. Banzato, and L. Tatò Fat cell size, insulin sensitivity, and inflammation in obese children J. Pediatr. 151 2007 647 652
38. M.J. Czaja Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications Am. J. Physiol. Cell Physiol. 298 2010 C973 C978
39. E.D. Rosen, and B.M. Spiegelman Molecular regulation of adipogenesis Annu. Rev. Cell Dev. Biol. 16 2000 145 171
40. E.D. Rosen, C.J. Walkey, P. Puigserver, and B.M. Spiegelman Transcriptional regulation of adipogenesis Genes Dev. 14 2000 1293 1307
41. F.M. Gregoire, C.M. Smas, and H.S. Sul Understanding adipocyte differentiation Physiol. Rev. 78 1998 783 809
42. J.M. Moreno-Navarrete, and J.M. Fernández-Real Adipocyte differentiation Adipose tissue biology: Springer Science+Business Media 2012 17 38
43. H. Hauner, G. Entenmann, M. Wabitsch, D. Gaillard, G. Ailhaud, R. Negrel, and E.F. Pfeiffer Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium J. Clin. Invest. 84 1989 1663 1670
44. D.F. Pinney, and C.P. Emerson Jr 10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation Environ. Health Perspect. 80 1989 221 227
45. G. Ailhaud Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome C. R. Biol. 329 2006 570 577
46. S. Gesta, Y.H. Tseng, and C.R. Kahn Developmental origin of fat: tracking obesity to its source Cell 131 2007 242 256
47. A.J. Friedenstein, U.F. Deriglasova, N.N. Kulagina, A.F. Panasuk, S.F. Rudakowa, E.A. Luria, and I.A. Ruadkow Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method Exp. Hematol. 2 1974 83 92
48. E.M. Horwitz, B.K. Le, M. Dominici, I. Mueller, I. Slaper-Cortenbach, F.C. Marini, R.J. Deans, D.S. Krause, and A. Keating Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement Cytotherapy 7 2005 393 395
49. J.M. Gimble, A.J. Katz, and B.A. Bunnell Adipose-derived stem cells for regenerative medicine Circ. Res. 100 2007 1249 1260
50. T.S. Housman, N. Lawrence, B.G. Mellen, M.N. George, J.S. Filippo, K.A. Cerveny, M. DeMarco, S.R. Feldman, and A.B. Fleischer The safety of liposuction: results of a national survey Dermatol. Surg. 28 2002 971 978
51. A.G. Cristancho, and M.A. Lazar Forming functional fat: a growing understanding of adipocyte differentiation Nat. Rev. Mol. Cell. Biol. 12 2011 722 734
52. E.D. Rosen, and O.A. MacDougald Adipocyte differentiation from the inside out Nat. Rev. Mol. Cell. Biol. 7 2006 885 896
53. S.R. Farmer Transcriptional control of adipocyte formation Cell Metab. 4 2006 263 273
54. M.I. Lefterova, and M.A. Lazar New developments in adipogenesis Trends Endocrinol. Metab. 20 2009 107 114
55. P. Tontonoz, and B.M. Spiegelman Fat and beyond: the diverse biology of PPARgamma Annu. Rev. Biochem. 77 2008 289 312
56. D.P. Ramji, and P. Foka CCAAT/enhancer-binding proteins: structure, function and regulation Biochem. J. 365 2002 561 575
57. Q.Q. Tang, and M.D. Lane Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation Genes Dev. 13 1999 2231 2241
58. W.C. Yeh, Z. Cao, M. Classon, and S.L. McKnight Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins Genes Dev. 9 1995 168 181
59. T. Tanaka, N. Yoshida, T. Kishimoto, and S. Akira Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene EMBO J. 16 1997 7432 7443
60. Q.Q. Tang, T.C. Otto, and M.D. Lane CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis Proc. Natl. Acad. Sci. USA 100 2003 850 855
61. Y.X. Wang, C.H. Lee, S. Tiep, R.T. Yu, J. Ham, H. Kang, and R.M. Evans Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity Cell 113 2003 159 170
62. G.J. Darlington, S.E. Ross, and O.A. MacDougald The role of C/EBP genes in adipocyte differentiation J. Biol. Chem. 273 1998 30057 30060
63. J.W. Kim, Q.Q. Tang, X. Li, and M.D. Lane Effect of phosphorylation and S-S bond-induced dimerization on DNA binding and transcriptional activation by C/EBPbeta Proc. Natl. Acad. Sci. USA 104 2007 1800 1804
64. Z. Chen, J.I. Torrens, A. Anand, B.M. Spiegelman, and J.M. Friedman Krox20 stimulates adipogenesis via C/EBPβ-dependent and -independent mechanisms Cell Metab. 1 2005 93 106
65. K. Birsoy, Z. Chen, and J. Friedman Transcriptional regulation of adipogenesis by KLF4 Cell Metab. 7 2008 339 347
66. H.G. Linhart, K. Ishimura-Oka, F. DeMayo, T. Kibe, D. Repka, B. Poindexter, R.J. Bick, and G.J. Darlington C/EBPalpha is required for differentiation of white, but not brown, adipose tissue Proc. Natl. Acad. Sci. USA 98 2001 12532 12537
67. S.O. Freytag, D.L. Paielli, and J.D. Gilbert Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells Genes Dev. 8 1994 1654 1663
68. E.D. Rosen, C.H. Hsu, X. Wang, S. Sakai, M.W. Freeman, F.J. Gonzalez, and B.M. Spiegelman C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway Genes Dev. 16 2002 22 26
69. S.L. Clarke, C.E. Robinson, and J.M. Gimble CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter Biochem. Biophys. Res. Commun. 240 1997 99 103
70. Z. Wu, E.D. Rosen, R. Brun, S. Hauser, G. Adelmant, A.E. Troy, C. McKeon, G.J. Darlington, and B.M. Spiegelman Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity Mol. Cell 3 1999 151 158
71. D. Shao, and M.A. Lazar Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation J. Biol. Chem. 272 1997 21473 21478
72. R.M. Evans, G.D. Barish, and Y.X. Wang PPARs and the complex journey to obesity Nat. Med 10 2004 355 361
73. J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, S.M. Hofmann, T. Schraw, J.L. Durand, H. Li, G. Li, L.A. Jelicks, M.F. Mehler, D.Y. Hui, Y. Deshaies, G.I. Shulman, G.J. Schwartz, and P.E. Scherer Obesity-associated improvements in metabolic profile through expansion of adipose tissue J. Clin. Invest. 117 2007 2621 2637
74. E. Weerapana, C. Wang, G.M. Simon, F. Richter, S. Khare, M.B. Dillon, D.A. Bachovchin, K. Mowen, D. Baker, and B.F. Cravatt Quantitative reactivity profiling predicts functional cysteines in proteomes Nature 468 2010 790 795
75. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
76. K.M. Cadigan, and Y.I. Liu Wnt signaling: complexity at the surface J. Cell Sci. 119 2006 395 402
77. Y. Kamei, T. Suganami, T. Kohda, F. Ishino, K. Yasuda, S. Miura, O. Ezaki, and Y. Ogawa Peg1/Mest in obese adipose tissue is expressed from the paternal allele in an isoform-specific manner FEBS Lett. 581 2007 91 96
78. H.S. Sul Pref-1: role in adipogenesis and mesenchymal cell fate Mol. Endocrinol. 23 2009 1717 1725
79. M. Styner, B. Sen, Z. Xie, N. Case, and J. Rubin Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism J. Cell Biochem. 111 2010 1042 1050
80. Z. Wu, N.L. Bucher, and S.R. Farmer Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids Mol. Cell. Biol. 16 1996 4128 4136
81. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor Cell 79 1994 1147 1156
82. J.J. Tomlinson, A. Boudreau, D. Wu, E. Atlas, and R.J. Hache Modulation of early human preadipocyte differentiation by glucocorticoids Endocrinology 147 2006 5284 5293
83. J.W. Zhang, D.J. Klemm, C. Vinson, and M.D. Lane Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis J. Biol. Chem. 279 2004 4471 4478
84. R.K. Petersen, L. Madsen, L.M. Pedersen, P. Hallenborg, H. Hagland, K. Viste, S.O. Doskeland, and K. Kristiansen Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes Mol. Cell. Biol. 28 2008 3804 3816
85. A.M. Oberbauer The influence of growth hormone on bone and adipose programming Adv. Exp. Med. Biol. 814 2014 169 176
86. J. Xu, and K. Liao Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation J. Biol. Chem. 279 2004 35914 35922
87. B.C. Reed, S.H. Kaufmann, J.C. Mackall, A.K. Student, and M.D. Lane Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes Proc. Natl. Acad. Sci. USA 74 1977 4876 4880
88. X. Wang, and C.X. Hai ROS acts as a double-edged sword in the pathogenesis of type 2 diabetes mellitus: is Nrf2 a potential target for the treatment? Mini-Rev. Med. Chem. 11 2011 1082 1092
89. X. Wang, L. Tao, and C.X. Hai Redox-regulating role of insulin: the essence of insulin effect Mol. Cell. Endocrinol. 349 2011 111 127
90. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura Increased oxidative stress in obesity and its impact on metabolic syndrome J. Clin. Invest. 114 2004 1752 1761
91. H. Urakawa, A. Katsuki, Y. Sumida, E.C. Gabazza, S. Murashima, K. Morioka, N. Maruyama, N. Kitagawa, T. Tanaka, Y. Hori, K. Nakatani, Y. Yano, and Y. Adachi Oxidative stress is associated with adiposity and insulin resistance in men J. Clin. Endocrinol. Metab. 88 2003 4673 4676
92. J.F. Keaney Jr, M.G. Larson, R.S. Vasan, P.W. Wilson, I. Lipinska, D. Corey, J.M. Massaro, P. Sutherland, J.A. Vita, and E.J. Benjamin Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study Arterioscler. Thromb. Vasc. Biol. 23 2003 434 439
93. A. Festa Jr, R. D'Agostino, K. Williams, A.J. Karter, E.J. Mayer-Davis, R.P. Tracy, and S.M. Haffner The relation of body fat mass and distribution to markers of chronic inflammation Int. J. Obes. Relat. Metab. Disord 25 2001 1407 1415
94. F. Armutcu, M. Ataymen, H. Atmaca, and A. Gurel Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome Clin. Chem. Lab. Med. 46 2008 785 790
95. V.O. Palmieri, I. Grattagliano, P. Portincasa, and G. Palasciano Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome J. Nutr. 136 2006 3022 3026
96. B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M.J. Chapman, and A. Kontush Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity J. Clin. Endocrinol. Metab. 89 2004 4963 4971
97. G. Block, M. Dietrich, E.P. Norkus, J.D. Morrow, M. Hudes, B. Caan, and L. Packer Factors associated with oxidatives tress in human populations Am. J. Epidemiol. 156 2002 274 285
98. P.M.P.G. Dandona, A. Prabhala, A. Afzal, and R. Garg The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipidperoxidation, and proteincarbonylation J. Clin. Endocrinol. Metab. 86 2001 355 362
99. S.O. Olusi Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans Int. J. Obes. Relat. Metab. Disord 26 2002 1159 1164
100. A.P. Russell, G. Gastaldi, E. Bobbioni-Harsch, P. Arboit, C. Gobelet, O. Deriaz, A. Golay, J.L. Witztum, and J.P. Giacobino Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids? FEBS Lett. 551 2003 104 106
101. A. Reitman, I. Friedrich, A. Ben-Amotz, and Y. Levy Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity ISR Med. Assoc. J. 4 2002 590 593
102. M. Sankhla, T.K. Sharma, K. Mathur, J.S. Rathor, V. Butolia, A.K. Gadhok, S.K. Vardey, M. Sinha, and G.G. Kaushik Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome Clin. Lab. 58 2012 385 392
103. M.E. Atabek, H. Vatansev, and I. Erkul Oxidative stress inchildhood obesity J. Pediatr. Endocrinol. Metab. 17 2004 1063 1068
104. N. Gletsu-Miller, J.M. Hansen, D.P. Jones, Y.M. Go, W.E. Torres, T.R. Ziegler, and E. Lin Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery Obesity (Silver Spring) 17 2009 439 446
105. K. Fujita, H. Nishizawa, T. Funahashi, I. Shimomura, and M. Shimabukuro Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome Circ. J. 70 2006 1437 1442
106. N. Matsuzawa-Nagata, T. Takamura, H. Ando, S. Nakamura, S. Kurita, H. Misu, T. Ota, M. Yokoyama, M. Honda, K. Miyamoto, and S. Kaneko Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity Metabolism 57 2008 1071 1077
107. B.R. Imhoff, and J.M. Hansen Differential redox potential profiles during adipogenesis and osteogenesis Cell. Mol. Biol. Lett. 16 2011 149 161
108. J.P. DeLany, Z.E. Floyd, S. Zvonic, A. Smith, A. Gravois, E. Reiners, X. Wu, G. Kilroy, M. Lefevre, and J.M. Gimble Proteomic analysis of primary cultures of human adipose-derived stem cells: modulation by Adipogenesis Mol. Cell Proteomics 4 2005 731 740
109. G.I. Welsh, M.R. Griffiths, K.J. Webster, M.J. Page, and J.M. Tavare Proteome analysis of adipogenesis Proteomics 4 2004 1042 1051
110. L. Wilson-Fritch, A. Burkart, G. Bell, K. Mendelson, J. Leszyk, S. Nicoloro, M. Czech, and S. Corvera Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone Mol. Cell. Biol. 23 2003 1085 1094
111. D. Pessler-Cohen, P.H. Pekala, J. Kovsan, A. Bloch-Damti, A. Rudich, and N. Bashan GLUT4 repression in response to oxidative stress is associated with reciprocal alterations in C/EBP alpha and delta isoforms in 3T3-L1 adipocytes Arch. Physiol. Mol. Cell. Biol. Biochem 112 2006 3 12
112. A. Carrière, Y. Fernandez, M. Rigoulet, L. Penicaud, and L. Casteilla Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species FEBS Lett. 550 2003 163 167
113. A. Carrière, M.C. Carmona, Y. Fernandez, M. Rigoulet, R.H. Wenger, L. Penicaud, and L. Casteilla Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect J. Biol. Chem. 279 2004 40462 40469
114. W. Guo, W. Xie, and J. Han Modulation of adipocyte lipogenesis by octanoate: involvement of reactive oxygen species Nutr. Metab. (Lond.) 3 2006 30
115. H.S. Moon, C.S. Chung, H.G. Lee, T.G. Kim, Y.J. Choi, and C.S. Cho Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells Obesity (Silver Spring) 15 2007 2571 2582
116. J.T. Hwang, S.H. Kim, M.S. Lee, S.H. Kim, H.J. Yang, M.J. Kim, H.S. Kim, J. Ha, M.S. Kim, and D.Y. Kwon Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte Biochem. Biophys. Res. Commun. 364 2007 1002 1008
117. L. Manente, A. Lucariello, C. Costanzo, R. Viglietti, G. Parrella, R. Parrella, M. Gargiulo, A. De Luca, A. Chirianni, and V. Esposito Suppression of preadipocyte differentiation and promotion of adipocyte death by anti-HIV drugs In Vivo 26 2012 287 291
118. D.V. Chartoumpekis, and T.W. Kensler New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome Curr. Diabetes Rev. 9 2013 137 145
119. H.I. Krieger-Brauer, and H. Kather Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells Biochem. J. 307 Pt. 2 1995 549 556
120. H.I. Krieger-Brauer, P.K. Medda, and H. Kather Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2 J. Biol. Chem. 272 1997 10135 10143
121. H. Lee, Y.J. Lee, H. Choi, E.H. Ko, and J.W. Kim Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion J. Biol. Chem. 284 2009 10601 10609
122. Y. Saitoh, L. Xiao, H. Mizuno, S. Kato, H. Aoshima, H. Taira, K. Kokubo, and N. Miwa Novel polyhydroxylated fullerene suppresses intracellular oxidative stress together with repression of intracellular lipid accumulation during the differentiation of OP9 preadipocytes into adipocytes Free Radic. Res. 44 2010 1072 1081
123. S. Mouche, S.B. Mkaddem, W. Wang, M. Katic, Y.H. Tseng, S. Carnesecchi, K. Steger, M. Foti, C.A. Meier, P. Muzzin, C.R. Kahn, E. Ogier-Denis, and I. Szanto Reduced expression of the NADPH oxidase NOX4 is a hallmark of adipocyte differentiation Biochim. Biophys. Acta 1773 2007 1015 1027
124. Y. Hou, P. Xue, Y. Bai, D. Liu, C.G. Woods, K. Yarborough, J. Fu, Q. Zhang, G. Sun, S. Collins, J.Y. Chan, M. Yamamoto, M.E. Andersen, and J. Pi Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein beta during adipogenesis Free Radic. Biol. Med. 52 2012 462 472
125. K. Mahadev, X. Wu, A. Zilbering, L. Zhu, J. Todd, and R. Lawrence Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes J. Biol. Chem. 276 2001 48662 48669
126. Y.M. Go, and D.P. Jones Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state Circulation 111 2005 2973 2980
127. B.R. Imhoff, and J.M. Hansen Extracellular redox environments regulate adipocyte differentiation Differentiation 80 2010 31 39
128. N. Mercier, M. Moldes, H.K. El, and B. Feve Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells Biochem. J. 358 2001 335 342
129. C. Younce, and P. Kolattukudy MCP-1 induced protein promotes adipogenesis via oxidative stress, endoplasmic reticulum stress and autophagy Cell Physiol. Biochem. 30 2012 307 320
130. K.A. Nath, J.P. Grande, and A.J. Croatt Likely, S.; Hebbel, R. P.; Enright, H. Intracellular targets in heme proteininduced renal injury Kidney Int. 53 1998 100 111
131. J. Balla, H.S. Jacob, G. Balla, K. Nath, J.W. Eaton, and G.M. Vercellotti Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage Proc. Natl. Acad. Sci. USA 90 1993 9285 9289
132. N. Puri, K. Sodhi, M. Haarstad, D.H. Kim, S. Bohinc, E. Foglio, G. Favero, and N.G. Abraham Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-adipocytes J. Cell Biochem. 113 2012 1926 1935
133. J.J. Chen, and I.M. London Hemin enhances the differentiation of mouse 3T3 cells to adipocytes Cell 26 1981 117 122
134. Q.Q. Tang, and M.D. Lane Adipogenesis: from stem cell to adipocyte Annu. Rev. Biochem. 81 2012 715 736
135. R.J. Soberman The expanding network of redox signaling: new observations, complexities, and perspectives J. Clin. Invest. 111 2003 571 574
136. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189
137. A. Boveris, and B. Chance The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen Biochem. J. 134 1973 707 716
138. J.F. Turrens, A. Alexandre, and A.L. Lehninger Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria Arch Biochem. Biophys 237 1985 408 414
139. J.F. Turrens Superoxide production by the mitochondrial respiratory chain Biosci. Rep. 17 1997 3 8
140. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino, and M. Brownlee Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
141. S. Nemoto, K. Takeda, Z.X. Yu, V.J. Ferrans, and T. Finkel Role for mitochondrial oxidants as regulators of cellular metabolism Mol. Cell. Biol. 20 2000 7311 7318
142. V. Skop, M. Cahova, H. Dankova, Z. Papackova, E. Palenickova, P. Svoboda, J. Zidkova, and L. Kazdova Autophagy inhibition in early but not in later stages prevents 3T3-L1 differentiation: effect on mitochondrial remodeling Differentiation 2014
143. T. Kita, H. Nishida, H. Shibata, S. Niimi, T. Higuti, and N. Arakaki Possible role of mitochondrial remodelling on cellular triacylglycerol accumulation J. Biochem. 146 2009 787 796
144. B.W. Newton, S.M. Cologna, C. Moya, D.H. Russell, W.K. Russell, and A. Jayaraman Proteomic analysis of 3T3-L1 adipocyte mitochondria during differentiation and enlargement J. Proteome Res. 10 2011 4692 4702
145. M.J. Ryu, S.J. Kim, M.J. Choi, Y.K. Kim, M.H. Lee, S.E. Lee, H.K. Chung, S.B. Jung, H.J. Kim, K.S. Kim, Y.S. Jo, G.R. Kweon, C.H. Lee, and M. Shong Mitochondrial oxidative phosphorylation reserve is required for hormone- and PPARgamma agonist-induced adipogenesis Mol. Cells 35 2013 134 141
146. J.X. Rong, J.L. Klein, Y. Qiu, M. Xie, J.H. Johnson, K.M. Waters, V. Zhang, J.A. Kashatus, K.S. Remlinger, N. Bing, R.M. Crosby, T.K. Jackson, S.M. Witherspoon, J.T. Moore, T.E. Ryan, S.D. Neill, and J.C. Strum Rosiglitazone induces mitochondrial biogenesis in differentiated murine 3T3-L1 and C3H/10T1/2 adipocytes PPAR Res 2011 2011 179454
147. S.J. Goldman, Y. Zhang, and S. Jin Autophagic degradation of mitochondria in white adipose tissue differentiation Antioxid. Redox Signal. 14 2011 1971 1978
148. R.H. Lu, H. Ji, Z.G. Chang, S.S. Su, and G.S. Yang Mitochondrial development and the influence of its dysfunction during rat adipocyte differentiation Mol. Biol. Rep. 37 2010 2173 2182
149. J.Y. Zhou, and L. Li MicroRNAs are key regulators of brown adipogenesis Biochim. Biophys. Acta 1841 2014 1590 1595
150. D. Liu, Y. Lin, T. Kang, B. Huang, W. Xu, M. Garcia-Barrio, M. Olatinwo, R. Matthews, Y.E. Chen, and W.E. Thompson Mitochondrial dysfunction and adipogenic reduction by prohibitin silencing in 3T3-L1 cells PLos One 7 2012 e34315
151. C. Carpene, D. Daviaud, J. Boucher, S. Bour, V. Visentin, S. Gres, C. Duffaut, E. Fontana, X. Testar, J.S. Saulnier-Blache, and P. Valet Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes Metabolism 55 2006 1397 1405
152. D.J. Carothers, G. Pons, and M.S. Patel Induction of dihydrolipoamide dehydrogenase in 3T3-L1 cells during differentiation Biochem. J. 249 1988 897 902
153. G. Lenaz Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv. Exp. Med. Biol. 942 2012 93 136
154. I. Berniakovich, M. Trinei, M. Stendardo, E. Migliaccio, S. Minucci, P. Bernardi, P.G. Pelicci, and M. Giorgio p66Shc-generated oxidative signal promotes fat accumulation J. Biol. Chem. 283 2008 34283 34293
155. C. Laurino, and R. Cordera Role of IRS-1 and SHC activation in 3T3-L1 fibroblasts differentiation Growth Horm. IGF Res. 8 1998 363 367
156. R. Vettor, G. Milan, C. Franzin, M. Sanna, P. De Coppi, R. Rizzuto, and G. Federspil The origin of intermuscular adipose tissue and its pathophysiological implications Am. J. Physiol. Endocrinol. Metab. 297 2009 E987 E998
157. B.P. Tu, and J.S. Weissman Oxidative protein folding in eukaryotes: mechanisms and consequences J. Cell Biol. 164 2004 341 346
158. B. Bhandary, A. Marahatta, H.R. Kim, and H.J. Chae An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases Int. J. Mol. Sci. 14 2012 434 456
159. C.X. Santos, L.Y. Tanaka, J. Wosniak, and F.R. Laurindo Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase Antioxid. Redox Signal. 11 2009 2409 2427
160. D.R. Davydov Microsomal monooxygenase in apoptosis: another target for cytochrome c signaling? Trends Biochem. Sci. 26 2001 155 160
161. H.R. Kim, G.H. Lee, E.Y. Cho, S.W. Chae, T. Ahn, and H.J. Chae Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1 J. Cell Sci. 122 2009 1126 1133
162. M. Cnop, F. Foufelle, and L.A. Velloso Endoplasmic reticulum stress, obesity and diabetes Trends Mol. Med. 18 2012 59 68
163. J. Han, R. Murthy, B. Wood, B. Song, S. Wang, B. Sun, H. Malhi, and R.J. Kaufman ER stress signalling through eIF2alpha and CHOP, but not IRE1alpha, attenuates adipogenesis in mice Diabetologia 56 2013 911 924
164. H. Sha, Y. He, H. Chen, C. Wang, A. Zenno, H. Shi, X. Yang, X. Zhang, and L. Qi The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis Cell Metab. 9 2009 556 564
165. C.E. Lowe, R.J. Dennis, U. Obi, S. O'Rahilly, and J.J. Rochford Investigating the involvement of the ATF6alpha pathway of the unfolded protein response in adipogenesis Int. J. Obes. (Lond.) 36 2012 1248 1251
166. G. Zhu, R. Ye, D.Y. Jung, E. Barron, R.H. Friedline, V.M. Benoit, D.R. Hinton, J.K. Kim, and A.S. Lee GRP78 plays an essential role in adipogenesis and postnatal growth in mice FASEB J 27 2013 955 964
167. E. Bobrovnikova-Marjon, D. Pytel, M.J. Riese, L.P. Vaites, N. Singh, G.A. Koretzky, E.S. Witze, and J.A. Diehl PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation Mol. Cell. Biol. 32 2012 2268 2278
168. S. Basseri, S. Lhotak, A.M. Sharma, and R.C. Austin The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response J. Lipid. Res. 50 2009 2486 2501
169. M. Iwai, Y. Tomono, S. Inaba, H. Kanno, I. Senba, M. Mogi, and M. Horiuchi AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice Am. J. Hypertens. 22 2009 784 791
170. Y. Li, S. Mouche, T. Sajic, C. Veyrat-Durebex, R. Supale, D. Pierroz, S. Ferrari, F. Negro, U. Hasler, E. Feraille, S. Moll, P. Meda, C. Deffert, X. Montet, K.H. Krause, and I. Szanto Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity Int. J. Obes. (Lond.) 36 2012 1503 1513
171. K. Mahadev, H. Motoshima, X. Wu, J.M. Ruddy, R.S. Arnold, G. Cheng, J.D. Lambeth, and B.J. Goldstein The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction Mol. Cell. Biol. 24 2004 1844 1854
172. M.J. Ronis, N. Sharma, J. Vantrease, S.J. Borengasser, M. Ferguson, K.E. Mercer, M.A. Cleves, H. Gomez-Acevedo, and T.M. Badger Female mice lacking p47phox have altered adipose tissue gene expression and are protected against high fat-induced obesity Physiol. Genomics 45 2013 351 366
173. I. Levin, J. Petrasek, and G. Szabo The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis Alcohol Clin. Exp. Res. 36 2012 1397 1406
174. A.M. Robert, and L. Robert Xanthine oxido-reductase, free radicals and cardiovascular disease. A critical review Pathol. Oncol. Res. 20 2014 1 10
175. J.L. McManaman, C.A. Palmer, R.M. Wright, and M.C. Neville Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion J. Physiol. 545 2002 567 579
176. C. Vorbach, A. Scriven, and M.R. Capecchi The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland Genes Dev. 16 2002 3223 3235
177. K.J. Cheung, I. Tzameli, P. Pissios, I. Rovira, O. Gavrilova, T. Ohtsubo, Z. Chen, T. Finkel, J.S. Flier, and J.M. Friedman Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity Cell Metab. 5 2007 115 128
178. K.J. Seymour, L.E. Roberts, M.A. Fini, L.A. Parmley, T.L. Oustitch, and R.M. Wright Stress activation of mammary epithelial cell xanthine oxidoreductase is mediated by p38 MAPK and CCAAT/enhancer-binding protein-beta J. Biol. Chem. 281 2006 8545 8558
179. M. Cortes-Canteli, M. Wagner, W. Ansorge, and A. Perez-Castillo Microarray analysis supports a role for ccaat/enhancer-binding protein-beta in brain injury J. Biol. Chem. 279 2004 14409 14417
180. S.A. Sanders, R. Eisenthal, and R. Harrison NADH oxidase activity of human xanthine oxidoreductase - generation of superoxide anion Eur. J. Biochem. 245 1997 541 548
181. S. Moncada, R.M.J. Palmer, and E.A. Higgs Nitricoxide: physiology, pathophysiology and pharmacology Pharmacol. Rev. 43 1991 109 142
182. H. Yan, E. Aziz, G. Shillabeer, A. Wong, D. Shanghavi, A. Kermouni, M. Abdel-Hafez, and D.C. Lau Nitric oxide promotes differentiation of rat white preadipocytes in culture J. Lipid. Res. 43 2002 2123 2129
183. E. Nisoli, E. Clementi, C. Tonello, C. Sciorati, L. Briscini, and M.O. Carruba Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures Br. J. Pharmacol. 125 1998 888 894
184. A. Zima, A.E. Martynyuk, C.N. Seubert, T.E. Morey, C. Sumners, R.F. Cucchiara, and D.M. Dennis Antagonism of the positive dromotropic effect of isoproterenol by adenosine: role of nitric oxide, cGMP-dependent cAMP-phosphodiesterase and protein kinase G J. Mol. Cell. Cardiol. 32 2000 1609 1619
185. E. Nisoli, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, C. Sciorati, R. Bracale, A. Valerio, M. Francolini, S. Moncada, and M.O. Carruba Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide Science 299 2003 896 899
186. C. Ribiere, A.M. Jaubert, N. Gaudiot, D. Sabourault, M.L. Marcus, J.L. Boucher, D. Denis-Henriot, and Y. Giudicelli White adipose tissue nitric oxide synthase: a potential source for NO production Biochem. Biophys. Res. Commun. 222 1996 706 712
187. S. Engeli, J. Janke, K. Gorzelniak, J. Bohnke, N. Ghose, C. Lindschau, F.C. Luft, and A.M. Sharma Regulation of the nitric oxide system in human adipose tissue J. Lipid. Res. 45 2004 1640 1648
188. J.W. Choi, S.H. Pai, S.K. Kim, M. Ito, C.S. Park, and Y.N. Cha Increases in nitric oxide concentrations correlate strongly with body fat in obese humans Clin. Chem. 47 2001 1106 1109
189. M. Elizalde, M. Ryden, V. Van Harmelen, P. Eneroth, H. Gyllenhammar, C. Holm, S. Ramel, A. Olund, P. Arner, and K. Andersson Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans J. Lipid. Res. 41 2000 1244 1251
190. M. Ryden, M. Elizalde, V. Van Harmelen, A. Ohlund, J. Hoffstedt, S. Bringman, and K. Andersson Increased expression of eNOS protein in omental versus subcutaneous adipose tissue in obese human subjects Int. J. Obes. Relat. Metab. Disord 25 2001 811 815
191. A. Georgescu, D. Popov, A. Constantin, M. Nemecz, N. Alexandru, D. Cochior, and A. Tudor Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with type 2 diabetes Clin. Sci. (Lond.) 120 2011 463 472
192. P. Perez-Matute, M.J. Neville, G.D. Tan, K.N. Frayn, and F. Karpe Transcriptional control of human adipose tissue blood flow Obesity (Silver Spring) 17 2009 681 688
193. A. Valerio, A. Cardile, V. Cozzi, R. Bracale, L. Tedesco, A. Pisconti, L. Palomba, O. Cantoni, E. Clementi, S. Moncada, M.O. Carruba, and E. Nisoli TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents J. Clin. Invest. 116 2006 2791 2798
194. B.E. Sansbury, T.D. Cummins, Y. Tang, J. Hellmann, C.R. Holden, M.A. Harbeson, Y. Chen, R.P. Patel, M. Spite, A. Bhatnagar, and B.G. Hill Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype Circ. Res. 111 2012 1176 1189
195. A. Othman, S. Ahmad, S. Megyerdi, R. Mussell, K. Choksi, K.R. Maddipati, A. Elmarakby, N. Rizk, and M. Al-Shabrawey 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase PLos One 8 2013 e57254
196. M.R. Yun, H.M. Park, K.W. Seo, S.J. Lee, D.S. Im, and C.D. Kim 5-Lipoxygenase plays an essential role in 4-HNE-enhanced ROS production in murine macrophages via activation of NADPH oxidase Free Radic. Res. 44 2010 742 750
197. K.J. Cho, J.M. Seo, and J.H. Kim Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species Mol. Cells 32 2011 1 5
198. L. Madsen, R.K. Petersen, M.B. Sorensen, C. Jorgensen, P. Hallenborg, L. Pridal, J. Fleckner, E.Z. Amri, P. Krieg, G. Furstenberger, R.K. Berge, and K. Kristiansen Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process Biochem. J. 375 2003 539 549
199. S.K. Chakrabarti, B.K. Cole, Y. Wen, S.R. Keller, and J.L. Nadler 12/15-Lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes Obesity (Silver Spring) 17 2009 1563 1657
200. P. Hallenborg, C. Jorgensen, R.K. Petersen, S. Feddersen, P. Araujo, P. Markt, T. Langer, G. Furstenberger, P. Krieg, A. Koppen, E. Kalkhoven, L. Madsen, and K. Kristiansen Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity Mol. Cell. Biol. 30 2010 4077 4091
201. G. Furstenberger, N. Epp, K.M. Eckl, H.C. Hennies, C. Jorgensen, P. Hallenborg, K. Kristiansen, and P. Krieg Role of epidermis-type lipoxygenases for skin barrier function and adipocyte differentiation Prostaglandins Other Lipid Mediat. 82 2007 128 134
202. K. Hirata, K. Wada, Y. Murata, A. Nakajima, T. Yamashiro, and Y. Kamisaki Critical role of leukotriene B4 receptor signaling in mouse 3T3-L1 preadipocyte differentiation Lipids Health Dis. 12 2013 122
203. G. Shillabeer, V. Kumar, E. Tibbo, and D.C. Lau Arachidonic acid metabolites of the lipoxygenase as well as the cyclooxygenase pathway may be involved in regulating preadipocyte differentiation Metabolism 47 1998 461 466
204. M. Kondo, T. Oya-Ito, T. Kumagai, T. Osawa, and K. Uchida Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress J. Biol. Chem. 276 2001 12076 12083
205. K. Fujimori, and F. Amano Niacin promotes adipogenesis by reducing production of anti-adipogenic PGF2alpha through suppression of C/EBPbeta-activated COX-2 expression Prostaglandins Other Lipid Mediat. 94 2011 96 103
206. D.H. Kim, N. Puri, K. Sodhi, J.R. Falck, N.G. Abraham, J. Shapiro, and M.L. Schwartzman Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes J. Lipid. Res. 54 2013 786 793
207. B.M. Forman, P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma Cell 83 1995 803 812
208. M.A. Mazid, A.A. Chowdhury, K. Nagao, K. Nishimura, M. Jisaka, T. Nagaya, and K. Yokota Endogenous 15-deoxy-delta(12,14)-prostaglandin J(2) synthesized by adipocytes during maturation phase contributes to upregulation of fat storage FEBS Lett. 580 2006 6885 6890
209. L. Fajas, S. Miard, M.R. Briggs, and J. Auwerx Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase J. Lipid. Res. 44 2003 1652 1659
210. S. Ghoshal, D.B. Trivedi, G.A. Graf, and C.D. Loftin Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice J. Biol. Chem. 286 2011 889 898
211. H. Yan, A. Kermouni, M. Abdel-Hafez, and D.C. Lau Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells J. Lipid. Res. 44 2003 424 429
212. X. Chu, K. Nishimura, M. Jisaka, T. Nagaya, F. Shono, and K. Yokota Up-regulation of adipogenesis in adipocytes expressing stably cyclooxygenase-2 in the antisense direction Prostaglandins Other Lipid Mediat. 91 2010 1 9
213. M.H. Cha, I.C. Kim, B.H. Lee, and Y. Yoon Baicalein inhibits adipocyte differentiation by enhancing COX-2 expression J. Med. Food 9 2006 145 153
214. A.A. Eid, Y. Gorin, B.M. Fagg, R. Maalouf, J.L. Barnes, K. Block, and H.E. Abboud Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases Diabetes 58 2009 1201 1211
215. R.V. Priyadarsini, and S. Nagini Quercetin suppresses cytochrome P450 mediated ROS generation and NFkappaB activation to inhibit the development of 7,12-dimethylbenz[a] anthracene (DMBA) induced hamster buccal pouch carcinomas Free Radic. Res. 46 2012 41 49
216. J. Aubert, K. Begriche, L. Knockaert, M.A. Robin, and B. Fromenty Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role Clin. Res. Hepatol. Gastroenterol 35 2011 630 637
217. N. Nieto, S.L. Friedman, and A.I. Cederbaum Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species Hepatology 35 2002 62 73
218. Y. Han, H. Zhao, H. Tang, X. Li, J. Tan, Q. Zeng, and C. Sun 20-Hydroxyeicosatetraenoic acid mediates isolated heart ischemia/reperfusion injury by increasing NADPH oxidase-derived reactive oxygen species production Circ. J. 77 2013 1807 1816
219. Q. Zeng, Y. Han, Y. Bao, W. Li, X. Li, X. Shen, X. Wang, F. Yao, and S.T. O'Rourke Sun, C. 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes Am. J. Physiol. Heart Circ. Physiol 299 2010 H1109 H1117
220. S. Eid, R. Maalouf, A.A. Jaffa, J. Nassif, A. Hamdy, A. Rashid, F.N. Ziyadeh, and A.A. Eid 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway PLos One 8 2013 e70029
221. M. Kotlyar, and S.W. Carson Effects of obesity on the cytochrome P450 enzyme system Int. J. Clin. Pharmacol. Ther. 37 1999 8 19
222. A.L. Roe, G. Howard, R. Blouin, and J.E. Snawder Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice Int. J. Obes. Relat. Metab. Disord 23 1999 48 53
223. J. Li, E. Daly, E. Campioli, M. Wabitsch, and V. Papadopoulos De novo synthesis of steroids and oxysterols in adipocytes J. Biol. Chem. 289 2014 747 764
224. A.P. Burgess, L. Vanella, L. Bellner, K. Gotlinger, J.R. Falck, N.G. Abraham, M.L. Schwartzman, and A. Kappas Heme oxygenase (HO-1) rescue of adipocyte dysfunction in HO-2 deficient mice via recruitment of epoxyeicosatrienoic acids (EETs) and adiponectin Cell Physiol. Biochem. 29 2012 99 110
225. K.N. Theken, Y. Deng, R.N. Schuck, A. Oni-Orisan, T.M. Miller, M.A. Kannon, S.M. Poloyac, and C.R. Lee Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism Am. J. Physiol. Endocrinol. Metab. 302 2012 E500 E509
226. W. Zha, M.L. Edin, K.C. Vendrov, R.N. Schuck, F.B. Lih, J.L. Jat, J.A. Bradbury, L.M. DeGraff, K. Hua, K.B. Tomer, J.R. Falck, D.C. Zeldin, and C.R. Lee Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity J. Lipid. Res. 55 2014 2124 2136
227. D.H. Kim, L. Vanella, K. Inoue, A. Burgess, K. Gotlinger, V.L. Manthati, S.R. Koduru, D.C. Zeldin, J.R. Falck, M.L. Schwartzman, and N.G. Abraham Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma Stem Cells Dev. 19 2010 1863 1873
228. S. Lechpammer, M.W. Epperly, S. Zhou, S. Nie, J. Glowacki, and J.S. Greenberger Adipocyte differentiation in Sod2(-/-) and Sod2(+/+) murine bone marrow stromal cells is associated with low antioxidant pools Exp. Hematol. 33 2005 1201 1208
229. P. Calzadilla, D. Sapochnik, S. Cosentino, V. Diz, L. Dicelio, J.C. Calvo, and L.N. Guerra N-Acetylcysteine reduces markers of differentiation in 3T3-L1 adipocytes Int. J. Mol. Sci. 12 2011 6936 6951
230. T. Kojima, T. Norose, K. Tsuchiya, and K. Sakamoto Mouse 3T3-L1 cells acquire resistance against oxidative stress as the adipocytes differentiate via the transcription factor FoxO Apoptosis 15 2010 83 93
231. K.M. Pires, O. Ilkun, M. Valente, and S. Boudina Treatment with a SOD mimetic reduces visceral adiposity, adipocyte death, and adipose tissue inflammation in high fat-fed mice Obesity (Silver Spring) 22 2014 178 187
232. A.I. Ruperez, J. Olza, M. Gil-Campos, R. Leis, M.D. Mesa, R. Tojo, R. Canete, A. Gil, and C.M. Aguilera Are catalase -844A/G polymorphism and activity associated with childhood obesity? Antioxid. Redox Signal. 19 2013 1970 1975
233. S.C. Lu Glutathione synthesis Biochim. Biophys. Acta 1830 2013 3143 3153
234. J.D. Hayes, J.U. Flanagan, and I.R. Jowsey Glutathione transferases Annu. Rev. Pharmacol. Toxicol. 45 2005 51 88
235. H. Kobayashi, M. Matsuda, A. Fukuhara, R. Komuro, and I. Shimomura Dysregulated glutathione metabolism links to impaired insulin action in adipocytes Am. J. Physiol. Endocrinol. Metab. 296 2009 E1326 E1334
236. H.M. Findeisen, F. Gizard, Y. Zhao, H. Qing, K.L. Jones, D. Cohn, E.B. Heywood, and D. Bruemmer Glutathione depletion prevents diet-induced obesity and enhances insulin sensitivity Obesity (Silver Spring) 19 2011 2429 2432
237. T. Takahashi, T. Tabuchi, Y. Tamaki, K. Kosaka, Y. Takikawa, and T. Satoh Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism Biochem. Biophys. Res. Commun. 382 2009 549 554
238. K.J. Heard Acetylcysteine for acetaminophen poisoning N Engl J. Med. 359 2008 285 292
239. G. Marenzi, E. Assanelli, I. Marana, G. Lauri, J. Campodonico, M. Grazi, M. De Metrio, S. Galli, F. Fabbiocchi, P. Montorsi, F. Veglia, and A.L. Bartorelli N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty N. Engl. J. Med. 354 2006 2773 2782
240. J.R. Kim, H.H. Ryu, H.J. Chung, J.H. Lee, S.W. Kim, W.H. Kwun, S.H. Baek, and J.H. Kim Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation Exp. Mol. Med. 38 2006 162 172
241. K.J. Cho, H.E. Moon, H. Moini, L. Packer, D.Y. Yoon, and A.S. Chung Alpha-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways J. Biol. Chem. 278 2003 34823 34833
242. D.V. Chartoumpekis, P.G. Ziros, G.P. Sykiotis, A. Zaravinos, A.I. Psyrogiannis, V.E. Kyriazopoulou, D.A. Spandidos, and I.G. Habeos Nrf2 activation diminishes during adipocyte differentiation of ST2 cells Int. J. Mol. Med. 28 2011 823 828
243. H.M. Findeisen, K.J. Pearson, F. Gizard, Y. Zhao, H. Qing, K.L. Jones, D. Cohn, E.B. Heywood, R. de Cabo, and D. Bruemmer Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis PLos One 6 2011 e18532
244. J.P. McClung, C.A. Roneker, W. Mu, D.J. Lisk, P. Langlais, F. Liu, and X.G. Lei Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase Proc. Natl. Acad. Sci. USA 101 2004 8852 8857
245. A. Carazo, J. Leon, J. Casado, A. Gila, S. Delgado, A. Martin, L. Sanjuan, T. Caballero, J.A. Munoz, R. Quiles, A. Ruiz-Extremera, L.M. Alcazar, and J. Salmeron Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1 Obes. Surg. 21 2011 492 500
246. S.S. Chung, M. Kim, B.S. Youn, N.S. Lee, J.W. Park, I.K. Lee, Y.S. Lee, J.B. Kim, Y.M. Cho, H.K. Lee, and K.S. Park Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells Mol. Cell. Biol. 29 2009 20 30
247. Y.S. Lee, A.Y. Kim, J.W. Choi, M. Kim, S. Yasue, H.J. Son, H. Masuzaki, K.S. Park, and J.B. Kim Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress Mol. Endocrinol. 22 2008 2176 2189
248. A.M. Rajalin, M. Micoogullari, H. Sies, and H. Steinbrenner Upregulation of the thioredoxin-dependent redox system during differentiation of 3T3-L1 cells to adipocytes Biol. Chem. 395 2014 667 677
249. Y.C. Chang, Y.H. Yu, J.Y. Shew, W.J. Lee, J.J. Hwang, Y.H. Chen, Y.R. Chen, P.C. Wei, L.M. Chuang, and W.H. Lee Deficiency of NPGPx, an oxidative stress sensor, leads to obesity in mice and human EMBO Mol. Med 5 2013 1165 1179
250. C. Yin, Y. Xiao, W. Zhang, E. Xu, W. Liu, X. Yi, and M. Chang DNA microarray analysis of genes differentially expressed in adipocyte differentiation J. Biosci. 39 2014 415 423
251. I.R. Jowsey, S.A. Smith, and J.D. Hayes Expression of the murine glutathione S-transferase alpha3 (GSTA3) subunit is markedly induced during adipocyte differentiation: activation of the GSTA3 gene promoter by the pro-adipogenic eicosanoid 15-deoxy-delta12,14-prostaglandin J2 Biochem. Biophys. Res. Commun. 312 2003 1226 1235
252. L. Qiang, and S.R. Farmer C/EBPalpha-dependent induction of glutathione S-transferase zeta/maleylacetoacetate isomerase (GSTzeta/MAAI) expression during the differentiation of mouse fibroblasts into adipocytes Biochem. Biophys. Res. Commun. 340 2006 845 851
253. I.P. Lopez, A. Marti, F.I. Milagro, M.M.L. Zulet, M.J. Moreno-Aliaga, J.A. Martinez, and C. De Miguel DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats Obes. Res. 11 2003 188 194
254. Y. Funato, and H. Miki Nucleoredoxin, a novel thioredoxin family member involved in cell growth and differentiation Antioxid. Redox Signal. 9 2007 1035 1057
255. P. Patwari, L.J. Higgins, W.A. Chutkow, J. Yoshioka, and R.T. Lee The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange J. Biol. Chem. 281 2006 21884 21891
256. W.A. Chutkow, and R.T. Lee Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability J. Biol. Chem. 286 2011 29139 29145
257. W.A. Chutkow, A.L. Birkenfeld, J.D. Brown, H.Y. Lee, D.W. Frederick, J. Yoshioka, P. Patwari, R. Kursawe, S.W. Cushman, J. Plutzky, G.I. Shulman, V.T. Samuel, and R.T. Lee Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity Diabetes 59 2010 1424 1434
258. L. Billiet, C. Furman, G. Larigauderie, C. Copin, S. Page, J.C. Fruchart, K. Brand, and M. Rouis Enhanced VDUP-1 gene expression by PPARgamma agonist induces apoptosis in human macrophage J. Cell Physiol. 214 2008 183 191
259. W. Qi, X. Chen, J. Holian, C.Y. Tan, D.J. Kelly, and C.A. Pollock Transcription factors Krüppel-like factor 6 and peroxisome proliferator-activated receptor-{gamma} mediate high glucose-induced thioredoxin-interacting protein Am. J. Pathol. 175 2009 1858 1867
260. Y.J. Bahn, K.P. Lee, S.M. Lee, J.Y. Choi, Y.S. Seo, and K.S. Kwon Nucleoredoxin promotes adipogenic differentiation through regulation of Wnt/beta-catenin signaling J. Lipid. Res. 56 2015 294 303
261. M. Hiroi, Y. Nagahara, R. Miyauchi, Y. Misaki, T. Goda, N. Kasezawa, S. Sasaki, and K. Yamakawa-Kobayashi The combination of genetic variations in the PRDX3 gene and dietary fat intake contribute to obesity risk Obesity (Silver Spring) 19 2011 882 887
262. J.Y. Huh, Y. Kim, J. Jeong, J. Park, I. Kim, K.H. Huh, Y.S. Kim, H.A. Woo, S.G. Rhee, K.J. Lee, and H. Ha Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression Antioxid. Redox Signal. 16 2012 229 243
263. A.T. Dinkova-Kostova, and P. Talalay NAD(P)H:quinone accept or oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector Arch. Biochem. Biophys. 501 2010 116 123
264. J. Palming, K. Sjöholm, M. Jernås, T.C. Lystig, A. Gummesson, S. Romeo, L. Löhn, M. Löhn, B. Carlsson, and L.M.S. Carlsson The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss,and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction J. Clin. Endocrinol. Metab. 92 2007 2346 2352
265. A. Gaikwad, D.J. LongII, J.L. Stringer, and A.K. Jaiswal In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue J. Biol. Chem. 276 2001 22559 22564
266. E.E. Vomhof-DeKrey, and M.J. Picklo NAD(P)H:quinone oxidoreductase 1 activity reduces hypertrophy in 3T3-L1 adipocytes Free Radic. Biol. Med. 53 2012 690 700
267. G. Kikuchi, T. Yoshida, and M. Noguchi Heme oxygenase and heme degradation Biochem. Biophys. Res. Commun. 338 2005 558 567
268. R. Ollinger, K. Yamashita, M. Bilban, A. Erat, P. Kogler, M. Thomas, E. Csizmadia, A. Usheva, R. Margreiter, and F.H. Bach Bilirubin and biliverdin treatment of atherosclerotic diseases Cell Cycle 6 2007 39 43
269. N.G. Abraham, and A. Kappas Pharmacological and clinical aspects of heme oxygenase Pharmacol. Rev. 60 2008 79 127
270. S.J. da, T. Morishita, B. Escalante, R. Staudinger, G. Drummond, M.S. Goligorsky, J.D. Lutton, and N.G. Abraham Dual role of heme oxygenase in epithelial cell injury: contrasting effects of short-term and long-term exposure to oxidant stress J. Lab. Clin. Med. 128 1996 290 296
271. C.R. Bruce, A.L. Carey, J.A. Hawley, and M.A. Febbraio Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism Diabetes 52 2003 2338 2345
272. W. Bao, F. Song, X. Li, S. Rong, W. Yang, D. Wang, J. Xu, J. Fu, Y. Zhao, and L. Liu Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis Am. J. Epidemiol. 172 2010 631 636
273. A.L. Kruger, S.J. Peterson, M.L. Schwartzman, H. Fusco, J.A. McClung, M. Weiss, S. Shenouda, A.I. Goodman, M.S. Goligorsky, A. Kappas, and N.G. Abraham Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects J. Pharmacol. Exp. Ther. 319 2006 1144 1152
274. D.H. Kim, A.P. Burgess, M. Li, P.L. Tsenovoy, F. Addabbo, J.A. McClung, N. Puri, and N.G. Abraham Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells J. Pharmacol. Exp. Ther. 325 2008 833 840
275. M. Li, D.H. Kim, P.L. Tsenovoy, S.J. Peterson, R. Rezzani, L.F. Rodella, W.S. Aronow, S. Ikehara, and N.G. Abraham Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance Diabetes 57 2008 1235 1526
276. A. Burgess, L. Vanella, L. Bellner, M.L. Schwartzman, and N.G. Abraham Epoxyeicosatrienoic acids and heme oxygenase-1 interaction attenuates diabetes and metabolic syndrome complications Prostaglandins Other Lipid Mediat. 97 2012 1 16
277. J. Cao, S.J. Peterson, K. Sodhi, L. Vanella, I. Barbagallo, L.F. Rodella, M.L. Schwartzman, N.G. Abraham, and A. Kappas Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet Hypertension 60 2012 467 475
278. R.A. Galbraith, and A. Kappas Regulation of food intake and body weight by cobalt porphyrins in animals Proc. Natl. Acad. Sci. USA 86 1989 7653 7657
279. E. Csongradi, D.J. M, J.H. Dubinion, T. Vera, and D.E. Stec Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice Int. J. Obes. (Lond.) 36 2012 244 253
280. S.J. Peterson, D.H. Kim, M. Li, V. Positano, L. Vanella, L.F. Rodella, F. Piccolomini, N. Puri, A. Gastaldelli, C. Kusmic, A. L'Abbate, and N.G. Abraham The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice J. Lipid. Res. 50 2009 1293 1304
281. L. Vanella, D.H. Kim, D. Asprinio, S.J. Peterson, I. Barbagallo, A. Vanella, D. Goldstein, S. Ikehara, A. Kappas, and N.G. Abraham HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage Bone 46 2010 236 243
282. L. Vanella, D.H. Kim, K. Sodhi, I. Barbagallo, A.P. Burgess, J.R. Falck, M.L. Schwartzman, and N.G. Abraham Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes Prostaglandins Other Lipid Mediat. 96 2011 54 62
283. S.J. Peterson, G. Drummond, D.H. Kim, M. Li, A.L. Kruger, S. Ikehara, and N.G. Abraham L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice J. Lipid. Res. 49 2008 1658 1669
284. A. Burgess, M. Li, L. Vanella, D.H. Kim, R. Rezzani, L. Rodella, K. Sodhi, M. Canestraro, P. Martasek, S.J. Peterson, A. Kappas, and N.G. Abraham Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice Hypertension 56 2010 1124 1130
285. P.A. Hosick, A.A. Alamodi, M.V. Storm, M.U. Gousset, B.E. Pruett, W.R. Gray, J. Stout, and D.E. Stec Chronic carbon monoxide treatment attenuates development of obesity and remodels adipocytes in mice fed a high-fat diet Int. J. Obes. (Lond.) 38 2014 132 139
286. I. Barbagallo, A. Vanella, S.J. Peterson, D.H. Kim, D. Tibullo, C. Giallongo, L. Vanella, N. Parrinello, G.A. Palumbo, F. Di Raimondo, N.G. Abraham, and D. Asprinio Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation J. Bone Miner. Metab. 28 2010 276 288
287. L. Vanella, K. Sodhi, D.H. Kim, N. Puri, M. Maheshwari Jr, T.D. Hinds, L. Bellner, D. Goldstein, S.J. Peterson, J.I. Shapiro, and N.G. Abraham Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade Stem Cell Res. Ther 4 2013 28 41
288. A. Nicolai, M. Li, D.H. Kim, S.J. Peterson, L. Vanella, V. Positano, A. Gastaldelli, R. Rezzani, L.F. Rodella, G. Drummond, C. Kusmic, A. L'Abbate, A. Kappas, and N.G. Abraham Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats Hypertension 53 2009 508 515
289. K. Sodhi, N. Puri, D.H. Kim, T.D. Hinds, L.A. Stechschulte, G. Favero, L. Rodella, J.I. Shapiro, D. Jude, and N.G. Abraham PPARdelta binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats Int. J. Obes. (Lond.) 38 2013 456 465
290. J.Y. Huang, M.T. Chiang, and L.Y. Chau Adipose overexpression of heme oxygenase-1 does not protect against high fat diet-induced insulin resistance in mice PLos One 8 2013 e55369
291. L. Vanella, M. Li, D. Kim, G. Malfa, L. Bellner, T. Kawakami, and N.G. Abraham ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b Cell Cycle 11 2012 706 714
292. H. Tanaka, S. Nakamura, K. Onda, T. Tazaki, and T. Hirano Sofalcone, an anti-ulcer chalcone derivative, suppresses inflammatory crosstalk between macrophages and adipocytes and adipocyte differentiation: implication of heme-oxygenase-1 induction Biochem. Biophys. Res. Commun. 381 2009 566 571
293. J. Park, H.K. Rho, K.H. Kim, S.S. Choe, Y.S. Lee, and J.B. Kim Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity Mol. Cell. Biol. 25 2005 5146 5157
294. Y. Kabuyama, K. Oshima, T. Kitamura, M. Homma, J. Yamaki, M. Munakata, and Y. Homma Involvement of selenoprotein P in the regulation of redox balance and myofibroblast viability in idiopathic pulmonary fibrosis Genes Cells 12 2007 1235 1244
295. R.F. Burk, K.E. Hill, and P. Selenoprotein A selenium-rich extracellular glycoprotein J. Nutr. 124 1994 1891 1897
296. Y. Zhang, and X. Chen Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation Am. J. Physiol. Endocrinol. Metab. 300 2011 E77 E85
297. P. Coyle, J.C. Philcox, L.C. Carey, and A.M. Rofe Metallothionein: the multipurpose protein Cell Mol. Life Sci. 59 2002 627 647
298. B. Ye, W. Maret, and B.L. Vallee Zinc metallothionein imported into liver mitochondria modulates respiration Proc. Natl. Acad. Sci. USA 98 2001 2317 2322
299. R.D. Steven, and J.C. Robert Metallothionein expression in animals: a physiological perspectuve on function J. Nutr. 130 2000 1085 1088
300. N. Futakawa, M. Kondoh, S. Ueda, M. Higashimoto, M. Takiguchi, S. Suzuki, and M. Sato Involvement of oxidative stress in the synthesis of metallothionein induced by mitochondrial inhibitors Biol. Pharm. Bull. 29 2006 2016 2020
301. R. Jin, V.T. Chow, P.H. Tan, S.T. Dheen, W. Duan, and B.H. Bay Metallothionein 2A expression is associated with cell proliferation in breast cancer Carcinogenesis 23 2002 81 86
302. C. Schmidt, and D. Beyersmann Transient peaks in zinc and metallothionein levels during differentiation of 3T3-L1 cells Arch. Biochem. Biophys. 364 1999 91 98
303. P. Trathurn, J.S. Duncan, A.M. Wood, and J.H. Beattie Regulation of metallothionein gene expression and secretion in rat adipocytes differentiated from preadipocytes in primary culture Horm. Metab. Res. 32 2000 542 547
304. P. Trayhurn, J.S. Duncan, A.M. Wood, and J.H. Beattie Metallothionein gene expression and secretion in white adipose tissue Am. J. Physiol. Regul. Integr. Comp. Physiol 279 2000 R2329 R2335
305. M.S. Do, S.Y. Nam, S.E. Hong, K.W. Kim, J.S. Duncan, J.H. Beattie, and P. Trayhurn Metallothionein gene expression in human adipose tissue from lean and obese subjects Horm. Metab. Res. 34 2000 348 351
306. P. Trayhurn, J.S. Duncan, A.M. Wood, and J.H. Beattie Metallothionein gene expression and secretion in white adipose tissue Am. J. Physiol. 279 2000 R2329 R2335
307. M. Sato, T. Kawakami, M. Kondoh, M. Takiguchi, Y. Kadota, S. Himeno, and S. Suzuki Development of high-fat-diet-induced obesity in female metallothionein-null mice FASEB J 24 2010 2375 2384
308. S. Bour, M.C. Carmona, A. Galinier, S. Caspar-Bauguil, L. Van Gaal, B. Staels, L. Penicaud, and L. Casteilla Coenzyme Q as an antiadipogenic factor Antioxid. Redox Signal. 14 2011 403 413
309. W.S. Nam, K.M. Park, and J.W. Park RNA interference targeting cytosolic NADP(+)-dependent isocitrate dehydrogenase exerts anti-obesity effect in vitro and in vi Biochim. Biophys. Acta 1822 2012 1181 1188
310. L. Packer, E.H. Witt, and H. Tritschler J. alpha-Lipoic acid as a biological antioxidant Free Radic. Biol. Med. 19 1995 227 250
311. S.A. Doggrell Alpha-lipoic acid, an anti-obesity agent? Expert Opin. Investig. Drugs 13 2004 1641 1643
312. M.S. Kim, J.Y. Park, C. Namkoong, P.G. Jang, J.W. Ryu, H.S. Song, J.Y. Yun, I.S. Namgoong, J. Ha, I.S. Park, I.K. Lee, B. Viollet, J.H. Youn, H.K. Lee, and K.U. Lee Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase Nat. Med 10 2004 727 733
313. R.H. Mahmoud, and W.A. Elnour Comparative evaluation of the efficacy of ginger and orlistat on obesity management, pancreatic lipase and liver peroxisomal catalase enzyme in male albino rats Eur. Rev. Med. Pharmacol. Sci. 17 2013 75 83
314. P.E. Pergola, P. Raskin, R.D. Toto, C.J. Meyer, J.W. Huff, E.B. Grossman, M. Krauth, S. Ruiz, P. Audhya, H. Christ-Schmidt, J. Wittes, and D.G. Warnock Bardoxolone methyl and kidney function in CKD with type 2 diabetes N. Engl. J. Med. 365 2011 327 336
315. C.H. Liang, L.P. Chan, T.H. Chou, F.Y. Chiang, C.M. Yen, P.J. Chen, H.Y. Ding, and R.J. Lin Brazilein from Caesalpinia sappan L. antioxidant inhibits adipocyte differentiation and induces apoptosis through caspase-3 activity and anthelmintic activities against hymenolepis nana and anisakis simplex Evid. Based Complement. Alternat. Med 2013 2013 864892
316. H.H. Lim, S.J. Yang, Y. Kim, M. Lee, and Y. Lim Combined treatment of mulberry leaf and fruit extract ameliorates obesity-related inflammation and oxidative stress in high fat diet-induced obese mice J. Med. Food 16 2013 673 680
317. M.J. Seo, H.S. Choi, O.H. Lee, and B.Y. Lee Grateloupia lanceolata (Okamura) Kawaguchi, the edible red seaweed, inhibits lipid accumulation and reactive oxygen species production during differentiation in 3T3-L1 cells Phytother. Res. 27 2013 655 663
318. Y. Samuni, J.A. Cook, R. Choudhuri, W. Degraff, A.L. Sowers, M.C. Krishna, and J.B. Mitchell Inhibition of adipogenesis by Tempol in 3T3-L1 cells Free Radic. Biol. Med. 49 2010 667 673
319. M.P. Rani, M.S. Krishna, K.P. Padmakumari, K.G. Raghu, and A. Sundaresan Zingiber officinale extract exhibits antidiabetic potential via modulating glucose uptake, protein glycation and inhibiting adipocyte differentiation: an in vitro study J. Sci. Food Agric 92 2012 1948 1955
320. J. Campion, F.I. Milagro, D. Fernandez, and J.A. Martinez Diferential gene expression and adiposity reduction induced by ascorbic acid supplementation in a cafeteria model of obesity J. Physiol. Biochem. 62 2006 71 80
321. J.T. Hwang, S. Kim, and S.Y. Choi Inhibitory effect of (E)-1,2-di(3,5-dimethoxyphenyl)ethene on 3T3-L1 adiopocyte differentiation Pharmazie 65 2010 903 905
322. S. Chen, Z. Li, W. Li, Z. Shan, and W. Zhu Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK Can. J. Physiol. Pharmacol. 89 2011 793 799
323. J.T. Hwang, S. Kim, I. Choi, and S.Y. Choi Resveratrol analog 4-[2-(3,5-dimethoxyphenyl)vinyl] pyridine reduces differentiation of the 3T3-L1 adipocyte Pharm. Biol. 51 2013 96 99
324. H.Y. Sung, S.W. Kang, J.L. Kim, J. Li, E.S. Lee, J.H. Gong, S.J. Han, and Y.H. Kang Oleanolic acid reduces markers of differentiation in 3T3-L1 adipocytes Nutr. Res. 30 2010 831 839
325. O.H. Lee, M.J. Seo, H.S. Choi, and B.Y. Lee Pycnogenol(R) inhibits lipid accumulation in 3T3-L1 adipocytes with the modulation of reactive oxygen species (ROS) production associated with antioxidant enzyme responses Phytother. Res. 26 2012 403 411
326. Y.Y. Sung, T. Yoon, W.K. Yang, S.J. Kim, D.S. Kim, and H.K. Kim The Antiobesity Effect of Polygonum aviculare L. Ethanol extract in high-fat diet-induced obese mice Evid. Based Complement. Alternat. Med 2013 2013 626397
327. Y.J. Lee, K.J. Kim, K.J. Park, B.R. Yoon, J.H. Lim, and O.H. Lee Buckwheat (Fagopyrum esculentum M.) sprout treated with methyl jasmonate (MeJA) improved anti-adipogenic activity associated with the oxidative stress system in 3T3-L1 adipocytes Int. J. Mol. Sci. 14 2013 1428 1442
328. R. Drira, S. Chen, and K. Sakamoto Oleuropein and hydroxytyrosol inhibit adipocyte differentiation in 3T3-L1 cells Life Sci. 89 2011 708 716
329. T.J. Cawood, P. Moriarty, C. O'Farrelly, and D. O'Shea Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link J. Clin. Endocrinol. Metab. 92 2007 59 64
330. J.S. Yoon, H.J. Lee, M.K. Chae, S.Y. Lee, and E.J. Lee Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress J. Endocrinol. 216 2013 145 156
331. D. Abe, T. Saito, Y. Kubo, Y. Nakamura, and K. Sekiya A fraction of unripe kiwi fruit extract regulates adipocyte differentiation and function in 3T3-L1 cells Biofactors 36 2010 52 59
332. K. Hemmrich, C. Gummersbach, N. Pallua, C. Luckhaus, and K. Fehsel Clozapine enhances differentiation of adipocyte progenitor cells Mol. Psychiatry 11 2006 980 981
333. A. Dalla Libera, G. Scutari, R. Boscolo, M.P. Rigobello, and A. Bindoli Antioxidant properties of clozapine and related neuroleptics Free Radic. Res. 29 1998 151 157
334. O.H. Lee, D.H. Seo, C.S. Park, and Y.C. Kim Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells Biofactors 36 2010 459 467
335. M.B. Sporn, and K.T. Liby NRF2 and cancer: the good, the bad and the importance of context Nat. Rev. Cancer 12 2012 564 571
336. H. Zhu, K. Itoh, M. Yamamoto, J.L. Zweier, and Y. Li Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury FEBS Lett. 579 2005 3029 3036
337. A.T. Dinkova-Kostova, K.T. Liby, K.K. Stephenson, W.D. Holtzclaw, X. Gao, N. Suh, C. Williams, R. Risingsong, T. Honda, G.W. Gribble, M.B. Sporn, and P. Talalay Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress Proc. Natl. Acad. Sci. USA 102 2005 4584 4589
338. J.D. Hayes, M. McMahon, S. Chowdhry, and A.T. Dinkova-Kostova Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway Antioxid. Redox Signal. 13 2010 1713 1748
339. M.K. Kwak, N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T.W. Kensler Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival J. Biol. Chem. 278 2003 8135 8145
340. J. Dong, K.K. Sulik, and S.Y. Chen Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders Antioxid. Redox Signal. 10 2008 2023 2033
341. L.V. Favreau, and C.B. Pickett The rat quinone reductase antioxidant response element. Identification of the nucleotide sequence required for basal and inducible activity and detection of antioxidant response element-binding proteins in hepatoma and non-hepatoma cell lines J. Biol. Chem. 270 1995 24468 24474
342. D.C. Galloway, D.G. Blake, and L.I. McLellan Regulation of gamma-glutamylcysteine synthetase regulatory subunit (GLCLR) gene expression: identification of the major transcriptional start site in HT29 cells Biochim. Biophys. Acta 1446 1999 47 56
343. K.J. Hintze, A.S. Keck, J.W. Finley, and E.H. Jeffery Induction of hepatic thioredoxin reductase activity by sulforaphane, both in Hepa1c1c7 cells and in male Fisher 344 rats J. Nutr. Biochem. 14 2003 173 179
344. T. Ishii, K. Itoh, H. Sato, and S. Bannai Oxidative stress-inducible proteins in macrophages Free Radic. Res. 31 1999 351 355
345. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, and Y. Katoh An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322
346. T. Nguyen, P.J. Sherratt, and C.B. Pickett Regulatory mechanisms controlling gene expression mediated by the antioxidant response element Annu. Rev. Pharmacol. Toxicol. 43 2003 233 260
347. T.H. Rushmore, and C.B. Pickett Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants J. Biol. Chem. 265 1990 14648 14653
348. B. Wang, and G. Williamson Detection of a nuclear protein which binds specifically to the antioxidant responsive element (ARE) of the human NAD(P) H:quinone oxidoreductase gene Biochim. Biophys. Acta 1219 1994 645 652
349. H.S. Zhang, and S.Q. Wang Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells Biochem. Pharmacol. 73 2007 1358 1366
350. A.K. MacLeod, M. McMahon, S.M. Plummer, L.G. Higgins, T.M. Penning, K. Igarashi, and J.D. Hayes Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds Carcinogenesis 30 2009 1571 1580
351. T. Nguyen, P. Nioi, and C.B. Pickett The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress J. Biol. Chem. 284 2009 13291 13295
352. N.M. Reddy, V. Suryanarayana, D.V. Kalvakolanu, M. Yamamoto, T.W. Kensler, P.M. Hassoun, S.R. Kleeberger, and S.P. Reddy Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice J. Immunol. 183 2009 4601 4608
353. R.K. Thimmulappa, H. Lee, T. Rangasamy, S.P. Reddy, M. Yamamoto, T.W. Kensler, and S. Biswal Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis J. Clin. Invest. 116 2006 984 995
354. N.G. Innamorato, A.I. Rojo, A.J. Garcia-Yague, M. Yamamoto, M.L. de Ceballos, and A. Cuadrado The transcription factor Nrf2 is a therapeutic target against brain inflammation J. Immunol. 181 2008 680 689
355. S. Ruiz, P.E. Pergola, R.A. Zager, and N.D. Vaziri Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease Kidney Int. 83 2013 1029 1041
356. L.M. Aleksunes, S.A. Reisman, R.L. Yeager, M.J. Goedken, and C.D. Klaassen Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice J. Pharmacol. Exp. Ther. 333 2010 140 151
357. K.J. Pearson, K.N. Lewis, N.L. Price, J.W. Chang, E. Perez, M.V. Cascajo, K.L. Tamashiro, S. Poosala, A. Csiszar, Z. Ungvari, T.W. Kensler, M. Yamamoto, J.M. Egan, D.L. Longo, D.K. Ingram, P. Navas, and R. de Cabo Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction Proc. Natl. Acad. Sci. USA 105 2008 2325 2330
358. T.E. Sussan, J. Jun, R. Thimmulappa, D. Bedja, M. Antero, K.L. Gabrielson, V.Y. Polotsky, and S. Biswal Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice PLos One 3 2008 e3791
359. J. Pi, L. Leung, P. Xue, W. Wang, Y. Hou, D. Liu, E. Yehuda-Shnaidman, C. Lee, J. Lau, T.W. Kurtz, and J.Y. Chan Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity J. Biol. Chem. 285 2010 9292 9300
360. D.V. Chartoumpekis, P.G. Ziros, A.I. Psyrogiannis, A.G. Papavassiliou, V.E. Kyriazopoulou, G.P. Sykiotis, and I.G. Habeos Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice Diabetes 60 2011 2465 2473
361. J. Xu, S.R. Kulkarni, A.C. Donepudi, V.R. More, and A.L. Slitt Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice Diabetes 61 2012 3208 3218
362. A. Lau, N.F. Villeneuve, Z. Sun, P.K. Wong, and D.D. Zhang Dual roles of Nrf2 in cancer Pharmacol. Res. 58 2008 262 270
363. S. Shin, J. Wakabayashi, M.S. Yates, N. Wakabayashi, P.M. Dolan, S. Aja, K.T. Liby, M.B. Sporn, M. Yamamoto, and T.W. Kensler Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide Eur. J. Pharmacol. 620 2009 138 144
364. X. Wang, R. Liu, W. Zhang, X. Zhang, N. Liao, Z. Wang, W. Li, X. Qin, and C. Hai Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects Mol. Cell. Endocrinol. 376 2013 70 80
365. X. Wang, X.L. Ye, R. Liu, H.L. Chen, H. Bai, X. Liang, X.D. Zhang, Z. Wang, W.L. Li, and C.X. Hai Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases Chem. Biol. Interact. 184 2010 328 337
366. Z. Yu, W. Shao, Y. Chiang, W. Foltz, Z. Zhang, W. Ling, I.G. Fantus, and T. Jin Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2[corrected] (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice Diabetologia 54 2011 922 934
367. S.K. Panchal, L. Ward, and L. Brown Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats Eur. J. Nutr. 52 2013 559 568
368. S.K. Panchal, H. Poudyal, and L. Brown Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats J. Nutr. 142 2012 1026 1032
369. H.J. He, G.Y. Wang, Y. Gao, W.H. Ling, Z.W. Yu, and T.R. Jin Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice World J. Diabetes 3 2012 94 104
370. P.K. Bagul, H. Middela, S. Matapally, R. Padiya, T. Bastia, K. Madhusudana, B.R. Reddy, S. Chakravarty, and S.K. Banerjee Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats Pharmacol. Res. 66 2012 260 268
371. M. Tuzcu, N. Sahin, C. Orhan, C.A. Agca, F. Akdemir, Z. Tuzcu, J. Komorowski, and K. Sahin Impact of chromium histidinate on high fat diet induced obesity in rats Nutr. Metab. (Lond.) 8 2011 28
372. Y.K.J. Zhang, R.L. Eager, Y. Tanaka, and C.D.Y. Klaassen Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by amethionine-and choline-deficient diet Toxicol. Appl. Pharmacol. 245 2010 326 334
373. J. Huang, I. Tabbi-Anneni, V. Gunda, and L. Wang Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism Am. J. Physiol. Gastrointest. Liver Physiol. 299 2010 G1211 G1221
374. Y.K. Zhang, K.C. Wu, J. Liu, and C.D. Klaassen Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet Toxicol. Appl Pharmacol. 264 2012 305 314
375. A.R. Collins, A.A. Gupte, R. Ji, M.R. Ramirez, L.J. Minze, J.Z. Liu, M. Arredondo, Y. Ren, T. Deng, J. Wang, C.J. Lyon, and W.A. Hsueh Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury Arterioscler. Thromb. Vasc. Biol. 32 2012 2839 2846
376. Y. Tanaka, L.M. Aleksunes, R.L. Yeager, M.A. Gyamfi, N. Esterly, G.L. Guo, and C.D. Klaassen NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet J. Pharmacol. Exp. Ther. 325 2008 655 664
377. A.K. Meher, P.R. Sharma, V.A. Lira, M. Yamamoto, T.W. Kensler, Z. Yan, and N. Leitinger Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance Free Radic. Biol. Med. 52 2012 1708 1715
378. K. Chan, R. Lu, J.C. Chang, and Y.W. Kan NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development Proc. Natl. Acad. Sci. USA 93 1996 13943 13948
379. K. Yoshinari, N. Okino, T. Sato, J. Sugatani, and M. Miwa Induction of detoxifying enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and antioxidants Drug Metab. Dispos. 34 2006 1081 1089
380. S. Kim, I. Sohn, J.I. Ahn, K.H. Lee, Y.S. Lee, and Y.S. Lee Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model Gene 340 2004 99 109
381. X. Wang, H. Wu, H. Chen, R. Liu, J. Liu, T. Zhang, W. Yu, and C. Hai Does insulin bolster antioxidant defenses via the extracellular signal-regulated kinases-protein kinase B-nuclear factor erythroid 2 p45-related factor 2 pathway? Antioxid. Redox Signal. 16 2012 1061 1070
382. E.E. Vomhof-Dekrey, and M.S. Picklo The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism J. Nutr. Biochem. 23 2012 1201 1206
383. S. Shin, N. Wakabayashi, V. Misra, S. Biswal, G.H. Lee, E.S. Agoston, M. Yamamoto, and T.W. Kensler NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis Mol. Cell. Biol. 27 2007 7188 7197
384. M.S. Yates, M. Tauchi, F. Katsuoka, K.C. Flanders, K.T. Liby, T. Honda, G.W. Gribble, D.A. Johnson, J.A. Johnson, N.C. Burton, T.R. Guilarte, M. Yamamoto, M.B. Sporn, and T.W. Kensler Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol. Cancer Ther. 6 2007 154 162
385. D.T. Hughes, P.M. Martel, W.B. Kinlaw, and B.L. Eisenberg The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells Cancer Invest. 26 2008 118 127
386. B.N. Chorley, M.R. Campbell, X. Wang, M. Karaca, D. Sambandan, F. Bangura, P. Xue, J. Pi, S.R. Kleeberger, and D.A. Bell Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha Nucleic Acids Res. 40 2012 7416 7429
387. B. Lefebvre, Y. Benomar, A. Guedin, A. Langlois, N. Hennuyer, J. Dumont, E. Bouchaert, C. Dacquet, L. Penicaud, L. Casteilla, F. Pattou, A. Ktorza, B. Staels, and P. Lefebvre Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans J. Clin. Invest. 120 2010 1454 1468
388. N. Wakabayashi, S. Shin, S.L. Slocum, E.S. Agoston, J. Wakabayashi, M.K. Kwak, V. Misra, S. Biswal, M. Yamamoto, and T.W. Kensler Regulation of notch1 signaling by nrf2: implications for tissue regeneration Sci. Signal 3 2010 a52
389. E. Hinoi, S. Fujimori, L. Wang, H. Hojo, K. Uno, and Y. Yoneda Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation J. Biol. Chem. 281 2006 18015 18024
390. X.Y. Jiang, D.B. Lu, Y.Z. Jiang, L.N. Zhou, L.Q. Cheng, and B. Chen PGC-1alpha prevents apoptosis in adipose-derived stem cells by reducing reactive oxygen species production in a diabetic microenvironment Diabetes Res. Clin. Pract. 100 2013 368 375
391. P.I. Huang, Y.C. Chou, Y.L. Chang, Y. Chien, K.H. Chen, W.S. Song, C.H. Peng, C.H. Chang, S.D. Lee, K.H. Lu, Y.J. Chen, C.H. Kuo, C.C. Hsu, H.C. Lee, and M.C. Yung Enhanced differentiation of three-gene-reprogrammed induced pluripotent stem cells into adipocytes via adenoviral-mediated PGC-1alpha overexpression Int. J. Mol. Sci. 12 2011 7554 7568
392. P.I. Huang, Y.C. Chen, L.H. Chen, C.C. Juan, H.H. Ku, S.T. Wang, S.H. Chiou, G.Y. Chiou, C.W. Chi, C.C. Hsu, H.C. Lee, L.K. Chen, and C.L. Kao PGC-1alpha mediates differentiation of mesenchymal stem cells to brown adipose cells J. Atheroscler. Thromb. 18 2011 966 980
393. W. Yu, D. Cao, H. Zhou, Y. Hu, and T. Guo PGC-1alpha is responsible for survival of multiple myeloma cells under hyperglycemia and chemotherapy Oncol. Rep. 33 2015 2086 2092
394. D. Cao, L. Jin, H. Zhou, W. Yu, Y. Hu, and T. Guo Inhibition of PGC-1alpha after chemotherapy-mediated insult confines multiple myeloma cell survival by affecting ROS accumulation Oncol. Rep. 33 2015 899 904
395. P. Puigserver, Z. Wu, C.W. Park, R. Graves, M. Wright, and B.M. Spiegelman A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 1998 829 839
396. A. Karamitri, A.M. Shore, K. Docherty, J.R. Speakman, and M.A. Lomax Combinatorial transcription factor regulation of the cyclic AMP-response element on the Pgc-1alpha promoter in white 3T3-L1 and brown HIB-1B preadipocytes J. Biol. Chem. 284 2009 20738 20752
397. A.A. Sablina, A.V. Budanov, G.V. Ilyinskaya, L.S. Agapova, J.E. Kravchenko, and P.M. Chumakov The antioxidant function of the p53 tumor suppressor Nat. Med. 11 2005 1306 1313
398. S.P. Hussain, P. Amstad, P. He, A. Robles, S. Lupold, I. Kaneko, M. Ichimiya, S. Sengupta, L. Mechanic, S. Okamura, L.J. Hofseth, M. Moake, M. Nagashima, K.S. Forrester, and C.C. Harris p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis Cancer Res. 64 2004 2350 2356
399. K.P. Olive, D.A. Tuveson, Z.C. Ruhe, B. Yin, N.A. Willis, R.T. Bronson, D. Crowley, and T. Jacks Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome Cell 119 2004 847 860
400. C. Brynczka, P. Labhart, and B.A. Merrick NGF-mediated transcriptional targets of p53 in PC12 neuronal differentiation BMC Genomics 8 2007 139
401. A.V. Budanov, A.A. Sablina, E. Feinstein, E.V. Koonin, and P.M. Chumakov Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD Science 304 2004 596 600
402. P. Hallenborg, S. Feddersen, L. Madsen, and K. Kristiansen The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function Expert Opin. Ther. Targets 13 2009 235 246
403. N. Okita, N. Ishikawa, Y. Mizunoe, M. Oku, W. Nagai, Y. Suzuki, S. Matsushima, K. Mikami, H. Okado, T. Sasaki, and Y. Higami Inhibitory effect of p53 on mitochondrial content and function during adipogenesis Biochem. Biophys. Res. Commun. 446 2014 91 97
404. Q. Huang, M. Liu, X. Du, R. Zhang, Y. Xue, Y. Zhang, W. Zhu, D. Li, A. Zhao, and Y. Liu Role of p53 in preadipocyte differentiation Cell Biol. Int. 38 2014 1384 1393
405. P. Hallenborg, R.K. Petersen, S. Feddersen, U. Sundekilde, J.B. Hansen, B. Blagoev, L. Madsen, and K. Kristiansen PPARgamma ligand production is tightly linked to clonal expansion during initiation of adipocyte differentiation J. Lipid. Res. 55 2014 2491 2500
406. A. Molchadsky, O. Ezra, P.G. Amendola, D. Krantz, I. Kogan-Sakin, Y. Buganim, N. Rivlin, N. Goldfinger, V. Folgiero, R. Falcioni, R. Sarig, and V. Rotter p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity Cell Death Differ. 20 2013 774 783
407. A. Molchadsky, I. Shats, N. Goldfinger, M. Pevsner-Fischer, M. Olson, A. Rinon, E. Tzahor, G. Lozano, D. Zipori, R. Sarig, and V. Rotter p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner PLos One 3 2008 e3707
408. N. Yahagi, H. Shimano, T. Matsuzaka, Y. Najima, M. Sekiya, Y. Nakagawa, T. Ide, S. Tomita, H. Okazaki, Y. Tamura, Y. Iizuka, K. Ohashi, T. Gotoda, R. Nagai, S. Kimura, S. Ishibashi, J. Osuga, and N. Yamada p53 Activation in adipocytes of obese mice J. Biol. Chem. 278 2003 25395 25400
409. Y.F. Su, S.H. Yang, Y.H. Lee, B.C. Wu, S.C. Huang, C.M. Liu, S.L. Chen, Y.F. Pan, S.S. Chou, M.Y. Chou, and H.W. Yang Aspirin-induced inhibition of adipogenesis was p53-dependent and associated with inactivation of pentose phosphate pathway Eur J. Pharmacol. 738 2014 101 110
410. B. Porteiro, A. Diaz-Ruiz, G. Martinez, A. Senra, A. Vidal, M. Serrano, O. Gualillo, M. Lopez, M.M. Malagon, C. Dieguez, and R. Nogueiras Ghrelin requires p53 to stimulate lipid storage in fat and liver Endocrinology 154 2013 3671 3679
411. J. Anrather, G. Racchumi, and C. Iadecola NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox J. Biol. Chem. 281 2006 5657 5667
412. R.G. Allen, and M. Tresini Oxidative stress and gene regulation Free Radic. Biol. Med. 28 2000 463 499
413. M.E. Allan, and K.B. Storey Expression of NF-kappaB and downstream antioxidant genes in skeletal muscle of hibernating ground squirrels, Spermophilus tridecemlineatus Cell Biochem. Funct. 30 2012 166 174
414. P. Kaur, G. Kaur, and M.P. Bansal Tertiary-butyl hydroperoxide induced oxidative stress and male reproductive activity in mice: role of transcription factor NF-kappaB and testicular antioxidant enzymes Reprod. Toxicol. 22 2006 479 484
415. A.H. Berg, Y. Lin, M.P. Lisanti, and P.E. Scherer Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity Am. J. Physiol. Endocrinol. Metab. 287 2004 E1178 E1188
416. A. Dorronsoro, V. Lang, E. Jakobsson, I. Ferrin, J.M. Salcedo, J. Fernandez-Rueda, K. Fechter, M.S. Rodriguez, and C. Trigueros Identification of the NF-kappaB inhibitor A20 as a key regulator for human adipogenesis Cell Death Dis. 4 2013 e972
417. P.J. S, P. Hu, S.J. Burke, J.J. Collier, J. Chen, and L. Zhao The effects of NOD activation on adipocyte differentiation Obesity (Silver Spring) 21 2013 737 747
418. L. Wang, L. Li, X. Ran, M. Long, M. Zhang, Y. Tao, X. Luo, Y. Wang, Y. Jiao, X. Mao, and J. Ren Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF-kappaB pathway and downregulation of AMPK expression Cardiovasc. Toxicol. 13 2013 338 346
419. M. Tamai, T. Shimada, N. Hiramatsu, K. Hayakawa, M. Okamura, Y. Tagawa, S. Takahashi, S. Nakajima, J. Yao, and M. Kitamura Selective deletion of adipocytes, but not preadipocytes, by TNF-alpha through C/EBP- and PPARgamma-mediated suppression of NF-kappaB Lab. Invest. 90 2010 1385 1395
420. M.L. Jr Batista, S.B. Peres, M.E. McDonald, P.S. Alcantara, M. Olivan, J.P. Otoch, S.R. Farmer, and M. Seelaender Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors Cytokine 57 2012 9 16
421. P. Delerive, J.C. Fruchart, and B. Staels Peroxisome proliferator-activated receptors in inflammation control J. Endocrinol. 169 2001 453 459
422. E. Hinoi, T. Iezaki, K. Ozaki, and Y. Yoneda Nuclear factor-kappaB is a common upstream signal for growth differentiation factor-5 expression in brown adipocytes exposed to pro-inflammatory cytokines and palmitate Biochem. Biophys. Res. Commun. 452 2014 974 979
423. P.L. de Keizer, B.M. Burgering, and T.B. Dansen Forkhead box o as a sensor, mediator, and regulator of redox signaling Antioxid. Redox Signal. 14 2011 1093 1106
424. M. Katoh, and M. Katoh Human FOX gene family (Review) Int J. Oncol. 25 2004 1495 1500
425. Y. Honda, and S. Honda The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans FASEB J 13 1999 1385 1393
426. C.T. Murphy, S.A. McCarroll, C.I. Bargmann, A. Fraser, R.S. Kamath, J. Ahringer, H. Li, and C. Kenyon Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans Nature 424 2003 277 283
427. Y. Akasaki, O. Alvarez-Garcia, M. Saito, B. Carames, Y. Iwamoto, and M.K. Lotz FoxO transcription factors support oxidative stress resistance in human chondrocytes Arthritis Rheumatol 66 2014 3349 3358
428. C.B. Chiribau, L. Cheng, I.C. Cucoranu, Y.S. Yu, R.E. Clempus, and D. Sorescu FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts J. Biol. Chem. 283 2008 8211 8217
429. S. Iyer, E. Ambrogini, S.M. Bartell, L. Han, P.K. Roberson, R. de Cabo, R.L. Jilka, R.S. Weinstein, C.A. O'Brien, S.C. Manolagas, and M. Almeida FOXOs attenuate bone formation by suppressing Wnt signaling J. Clin. Invest. 123 2013 3409 3419
430. P. Dowell, T.C. Otto, S. Adi, and M.D. Lane Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways J. Biol. Chem. 278 2003 45485 45491
431. F. Wang, and Q. Tong SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma Mol. Biol. Cell 20 2009 801 808
432. J. Nakae, T. Kitamura, Y. Kitamura, W.R. Biggs, K.C. Arden, and D. Accili The forkhead transcription factor Foxo1 regulates adipocyte differentiation Dev. Cell 4 2003 119 129
433. K. Munekata, and K. Sakamoto Forkhead transcription factor Foxo1 is essential for adipocyte differentiation In Vitro Cell Dev. Biol. Anim. 45 2009 642 651
434. M. Higuchi, G.J. Dusting, H. Peshavariya, F. Jiang, S.T. Hsiao, E.C. Chan, and G.S. Liu Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes Stem Cells Dev. 22 2013 878 888
435. V.J. Victorino, A.L. Mencalha, and C. Panis Post-translational modifications disclose a dual role for redox stress in cardiovascular pathophysiology Life Sci. 2014
436. C. Waszczak, S. Akter, S. Jacques, J. Huang, J. Messens, and F. Van Breusegem Oxidative post-translational modifications of cysteine residues in plant signal transduction J. Exp. Bot. 2015
437. X. Wang, J.Z. Liu, J.X. Hu, H. Wu, Y.L. Li, H.L. Chen, H. Bai, and C.X. Hai ROS-activated p38 MAPK/ERK-Akt cascade plays a central role in palmitic acid-stimulated hepatocyte proliferation Free Radic. Biol. Med. 51 2011 539 551
438. A.H. Tseng, L.H. Wu, S.S. Shieh, and D.L. Wang SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia Biochem. J. 464 2014 157 168
439. Y.B. Liu, X. Gao, D. Deeb, A.S. Arbab, and S.C. Gautam Pristimerin induces apoptosis in prostate cancer cells by down-regulating Bcl-2 through ROS-dependent ubiquitin-proteasomal degradation pathway J. Carcinog. Mutagen 5 Suppl. 6 2013
440. K. Huang, J. Huang, X. Xie, S. Wang, C. Chen, X. Shen, P. Liu, and H. Huang Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-beta1 by activating the Nrf2/ARE pathway in glomerular mesangial cells Free Radic. Biol. Med. 65 2013 528 540
441. Y. Zhou, J. Peng, and S. Jiang Role of histone acetyltransferases and histone deacetylases in adipocyte differentiation and adipogenesis Eur. J. Cell Biol. 93 2014 170 177
442. J. Han, and R.J. Kaufman Measurement of the unfolded protein response to investigate its role in adipogenesis and obesity Methods Enzymol. 538 2014 135 150
443. J.H. Kim, K.W. Park, E.W. Lee, W.S. Jang, J. Seo, S. Shin, K.A. Hwang, and J. Song Suppression of PPARgamma through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation Cell Death Differ. 21 2014 594 603
444. J.H. Kim, S.H. Kim, S.Y. Song, W.S. Kim, S.U. Song, T. Yi, M.S. Jeon, H.M. Chung, Y. Xia, and J.H. Sung Hypoxia induces adipocyte differentiation of adipose-derived stem cells by triggering reactive oxygen species generation Cell Biol. Int. 38 2014 32 40
445. Y. Zhang, and J.H. Yang Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts J. Cell Biochem. 114 2013 2595 2602
446. C.M. Backesjo, Y. Li, U. Lindgren, and L.A. Haldosen Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells Cells Tissues Organs 189 2009 93 97
447. E. Jing, S. Gesta, and C.R. Kahn SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation Cell Metab. 6 2007 105 114
448. A. Giralt, E. Hondares, J.A. Villena, F. Ribas, J. Diaz-Delfin, M. Giralt, R. Iglesias, and F. Villarroya Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype J. Biol. Chem. 286 2011 16958 16966
449. R.J. Perry, J.P. Camporez, R. Kursawe, P.M. Titchenell, D. Zhang, C.J. Perry, M.J. Jurczak, A. Abudukadier, M.S. Han, X.M. Zhang, H.B. Ruan, X. Yang, S. Caprio, S.M. Kaech, H.S. Sul, M.J. Birnbaum, R.J. Davis, G.W. Cline, K.F. Petersen, and G.I. Shulman Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes Cell 160 2015 745 758
450. I. Turker, Y. Zhang, Y. Zhang, and J. Rehman Oxidative Stress as a Regulator of Adipogenesis FASEB J. 21 Meeting Abstract Supplement 2007 830